株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ビタミンK2の世界市場:将来予測

Global Vitamin K2 Market Research Report Forecast to 2023

発行 Market Research Future 商品コード 851699
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。
Back to Top
ビタミンK2の世界市場:将来予測 Global Vitamin K2 Market Research Report Forecast to 2023
出版日: 2019年04月30日 ページ情報: 英文 120 Pages
概要

当レポートでは、世界のビタミンK2 (メナキノン) の市場について分析し、製品の概要や市場の基本構造、主な市場促進・抑制要因、全体的な市場動向の見通し (過去3年間・今後6年間分)、製品種類別・原料別・形状別・用途別・地域別の詳細動向、市場シェア構造、主要企業のプロファイル・業績・戦略などを調査しております。

第1章 序論

第2章 エグゼクティブ・サマリー

第3章 市場概要

第4章 分析手法

  • 分析プロセス
  • 一次調査
  • 二次調査
  • 市場規模の推計値
  • 市場予測モデル
  • イントロダクション
  • 市場促進要因
  • 市場機会

第5章 市場要因の分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析

第6章 世界のビタミンK2市場:製品種類別

  • イントロダクション
  • MK-7 (メナキノン-7)
  • MK-4 (メナキノン-4)

第7章 世界のビタミンK2市場:原料別

  • イントロダクション
  • 天然
  • 合成

第8章 世界のビタミンK2市場:形状別

  • イントロダクション
  • 粉末状
  • 油状

第9章 世界のビタミンK2市場:用途別

  • イントロダクション
  • 食品、栄養補助食品 (ニュートラシューティカル)
  • 医薬品

第10章 世界のビタミンK2市場:地域別

  • イントロダクション
  • 南北アメリカ (北米 (米国、カナダ)、ラテンアメリカ)
  • 欧州 (西欧 (英国、ドイツ、フランス、イタリア、スペインなど)、東欧)
  • アジア太平洋地域 (オーストラリア、日本、中国、インド、韓国など)
  • 中東・アフリカ

第11章 競争環境

  • イントロダクション
  • 企業別市場シェアの分析

第12章 企業プロファイル

  • Kappa Bioscience
  • NattoPharma
  • Gnosis SpA
  • Viridis BioPharma
  • Seebio Biotech
  • DSM
  • Danisco A/S
  • Geneferm Biotechnology Co. Ltd
  • Frutarom
  • 協和発酵バイオ

第13章 付録

図表

List of Tables

  • TABLE 1 MARKET SYNOPSIS
  • TABLE 2 LIST OF ASSUMPTIONS
  • TABLE 3 GLOBAL VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 4 GLOBAL VITAMIN K2 MARKET FOR MK-7, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL VITAMIN K2 MARKET FOR MK-4, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL VITAMIN K2 MARKET FOR NATURAL, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL VITAMIN K2 MARKET FOR SYNTHETIC, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL VITAMIN K2 MARKET FOR POWDER, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 11 GLOBAL VITAMIN K2 MARKET FOR OIL, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 12 GLOBAL VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 13 GLOBAL VITAMIN K2 MARKET FOR NUTRACEUTICAL AND FOOD, BY REGION 2015-2023 (USD MILLION)
  • TABLE 14 GLOBAL VITAMIN K2 MARKET FOR PHARMACEUTICAL, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 15 GLOBAL VITAMIN K2 MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 16 AMERICAS: VITAMIN K2 MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 17 AMERICAS: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 18 AMERICAS: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 19 AMERICAS: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 20 AMERICAS: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 21 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 22 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 23 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 24 NORTH AMERICA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 25 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 26 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 27 US: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 28 US: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 29 US: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 30 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 31 CANADA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 32 CANADA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 33 CANADA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 34 LATIN AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 35 LATIN AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 36 LATIN AMERICA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 37 LATIN AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 38 EUROPE: VITAMIN K2 MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 39 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 40 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 41 EUROPE: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 42 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 43 WESTERN EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 44 WESTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 45 WESTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 46 WESTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 47 WESTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 48 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 49 UK: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 50 UK: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 51 UK: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 52 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 53 GERMANY: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 54 GERMANY: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 55 GERMANY: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 56 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 57 FRANCE: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 58 FRANCE: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 59 FRANCE: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 60 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 61 ITALY: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 62 ITALY: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 63 ITALY: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 64 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 65 SPAIN: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 66 SPAIN: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 67 SPAIN: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 68 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 69 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 70 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 71 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 72 EASTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 73 EASTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 74 EASTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 75 EASTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 76 ASIA-PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 77 ASIA-PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 78 ASIA-PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 79 ASIA-PACIFIC: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 80 ASIA-PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 81 AUSTRALIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 82 AUSTRALIA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 83 AUSTRALIA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 84 AUSTRALIA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 85 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 86 JAPAN: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 87 JAPAN: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 88 JAPAN: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 89 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 90 CHINA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 91 CHINA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 92 CHINA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 93 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 94 INDIA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 95 INDIA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 96 INDIA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 97 SOUTH KOREA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 98 SOUTH KOREA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 99 SOUTH KOREA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 100 SOUTH KOREA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 101 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 102 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 103 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 104 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 105 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 106 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 107 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 108 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 109 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 110 MIDDLE EAST: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 111 MIDDLE EAST: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 112 MIDDLE EAST: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 113 MIDDLE EAST: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 114 AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 115 AFRICA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 116 AFRICA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 117 AFRICA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)

List of Figures

  • FIGURE 1 RESEARCH PROCESS OF MRFR
  • FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACHES
  • FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL VITAMIN K2 MARKET
  • FIGURE 4 PORTER'S FIVE FORCES ANALYSIS: GLOBAL VITAMIN K2 MARKET
  • FIGURE 5 SUPPLY CHAIN ANALYSIS: GLOBAL VITAMIN K2 MARKET
  • FIGURE 6 GLOBAL VITAMIN K2 MARKET SHARE, BY TYPE, 2017(%)
  • FIGURE 7 GLOBAL VITAMIN K2 MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
  • FIGURE 8 GLOBAL VITAMIN K2 MARKET SHARE, BY SOURCE, 2017 (%)
  • FIGURE 9 GLOBAL VITAMIN K2 MARKET, BY SOURCE, 2017 & 2023 (USD MILLION)
  • FIGURE 10 GLOBAL VITAMIN K2 MARKET SHARE, BY FORM, 2017(%)
  • FIGURE 11 GLOBAL VITAMIN K2 MARKET, BY FORM, 2017 & 2023 (USD MILLION)
  • FIGURE 12 GLOBAL VITAMIN K2 MARKET SHARE, BY APPLICATION, 2017(%)
  • FIGURE 13 GLOBAL VITAMIN K2 MARKET, BY APPLICATION, 2017 & 2023 (USD MILLION)
  • FIGURE 14 GLOBAL VITAMIN K2 MARKET SHARE, BY REGION, 2017(%)
  • FIGURE 15 GLOBAL VITAMIN K2 MARKET, BY REGION, 2017 & 2023 (USD MILLION)
  • FIGURE 16 AMERICAS: VITAMIN K2 MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 17 EUROPE: VITAMIN K2 MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 18 ASIA-PACIFIC: VITAMIN K2 MARKET SHARE, BY COUNTRY, 2017 (%)
  • FIGURE 19 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 20 GLOBAL VITAMIN K2 MARKET, COMPANY MARKET SHARE ANALYSIS, 2017 (%)
目次

Vitamin K2 Market Research Report: by Product Type (MK-7, MK-4, Others), by Source (Natural, Synthetic), by Form (Oil, Powder, Others), by Application (Nutraceutical & Food, Pharmaceutical), and Region - Global Forecast till 2023

Market analysis

Vitamin K2, otherwise called menaquinones, are a compound group known for averting cardiovascular maladies and bone illnesses. The nutrient is in charge of guaranteeing calcium consumed by the bone network and avert its disposition in the arteries. The global vitamin K2 market is assessed to contact a valuation of USD 228.27 million by 2023, according to the most recent discoveries of Market Research Future (MRFR). It is anticipated to enlist 5.80% CAGR over the gauge time frame (2018-2025). It was recently esteemed at USD 45 million of every 2017. It is principally determined by the ascent in nutrient inadequacy cases. Increment in wellbeing awareness combined with the tendency of customers towards dietary enhancements can drive the global vitamin K2 market development. Rising instances of osteoporosis which can quicken maturing of tissues is another factor which can decidedly affect the market. However, exacting guidelines by government bureaucratic organizations for endorsement of supplements can go about as a development obstacle.

Market segmentation

The global vitamin K2 market is bifurcated on the basis of source, product type, form, application and regional demand. On the basis of its product type, the market is divided into MK-4, MK-7, and others. Based on its sources, the market is segmented into synthetic and nautral. On the basis of its form, the market is bifurcated into powder and oil. Based on its applications, the market include pharmaceutical and nutraceutical & food.

Regional analysis

Geographically, the global vitamin K2 market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

DSM (The Netherlands), Danisco A/S (U.S.), Geneferm Biotechnology Co. Ltd. (Taiwan), Frutarom (Israel), and Kyowa Hakko Bio Co. Ltd. (Japan), Kappa Bioscience (Norway), NattoPharma (Norway), Gnosis SpA (Italy), Viridis BioPharma (India), Seebio Biotech (China), among others are some of the key players in the global vitamin K2 market.

Table of Contents

1 Report Prologue

2 Executive Summary

3 Market Introduction

  • 3.1 Definition
  • 3.2 Scope of the Study
  • 3.3 List of Assumptions
  • 3.4 Market Structure

4 Research Methodology

  • 4.1 Research Process
  • 4.2 Primary Research
  • 4.3 Secondary Research
  • 4.4 Market Size Estimation
  • 4.5 Forecast Model
  • 4.6 Introduction
  • 4.7 Drivers
    • 4.7.1 Increasing patient pool suffering from vitamin deficiency
    • 4.7.2 Increasing demand for nutraceutical products containing vitamin K2
    • 4.7.3 Increasing cases of osteoporosis
  • 4.8 Restraints
    • 4.8.1 Stringent regulations for nutraceuticals adversely affect the market
  • 4.9 Opportunity
    • 4.9.1 Multifunctional ingredients

5 Market Factor Analysis

  • 5.1 Porter's Five Forces Model
    • 5.1.1 Bargaining Power of Suppliers
    • 5.1.2 Bargaining Power of Buyers
    • 5.1.3 Threat of New Entrants
    • 5.1.4 Threat of Substitutes
    • 5.1.5 Rivalry
  • 5.2 Supply Chain Analysis
    • 5.2.1 Raw Material Planning & Procurement
      • 5.2.1.1 Fermentation
      • 5.2.1.2 Filtration
      • 5.2.1.3 Extraction
      • 5.2.1.4 Filtration Purification
    • 5.2.2 Packaging
    • 5.2.3 Transportation
    • 5.2.4 Distribution Marketing & Sales
    • 5.2.5 Post-sales Services

6 Global Vitamin K2 Market, by Product Type

  • 6.1 Introduction
  • 6.2 MK-7
  • 6.3 MK-4

7 Global Vitamin K2 Market, by Source

  • 7.1 Introduction
  • 7.2 Natural
  • 7.3 Synthetic

8 Global Vitamin K2 Market, by Form

  • 8.1 Introduction
  • 8.2 Powder
  • 8.3 Oil

9 Global Vitamin K2 Market, by Application

  • 9.1 Introduction
  • 9.2 Nutraceutical and Food
  • 9.3 Pharmaceutical

10 Global Vitamin K2 Market, by Region

  • 10.1 Introduction
  • 10.2 Americas
    • 10.2.1 North America
      • 10.2.1.1 US
      • 10.2.1.2 Canada
    • 10.2.2 Latin America
  • 10.3 Europe
    • 10.3.1 Western Europe
      • 10.3.1.1 UK
      • 10.3.1.2 Germany
      • 10.3.1.3 France
      • 10.3.1.4 Italy
      • 10.3.1.5 Spain
      • 10.3.1.6 Rest of Western Europe
    • 10.3.2 Eastern Europe
  • 10.4 Asia-Pacific
    • 10.4.1 Australia
    • 10.4.2 Japan
    • 10.4.3 China
    • 10.4.4 India
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia-Pacific
  • 10.5 Middle East & Africa
    • 10.5.1 Middle East
    • 10.5.2 Africa

11 Competitive Landscape

  • 11.1 Introduction
  • 11.2 Company Market Share Analysis

12 Company Profiles

  • 12.1 Kappa Bioscience
    • 12.1.1 Company Overview
    • 12.1.2 Financial Overview
    • 12.1.3 Products/Services Offered
    • 12.1.4 Key Developments
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Strategies
  • 12.2 NattoPharma
    • 12.2.1 Company Overview
    • 12.2.2 Financial Overview
    • 12.2.3 Products/Services Offered
    • 12.2.4 Key Developments
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Strategies
  • 12.3 Gnosis SpA
    • 12.3.1 Company Overview
    • 12.3.2 Financial Overview
    • 12.3.3 Products/Services Offered
    • 12.3.4 Key Developments
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Strategies
  • 12.4 Viridis BioPharma
    • 12.4.1 Company Overview
    • 12.4.2 Financial Overview
    • 12.4.3 Products/Services Offered
    • 12.4.4 Key Developments
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Strategies
  • 12.5 Seebio Biotech
    • 12.5.1 Company Overview
    • 12.5.2 Financial Overview
    • 12.5.3 Products/Services Offered
    • 12.5.4 Key Developments
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Strategies
  • 12.6 DSM
    • 12.6.1 Company Overview
    • 12.6.2 Financial Overview
    • 12.6.3 Products/Services Offered
    • 12.6.4 Key Developments
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Strategies
  • 12.7 Danisco A/S
    • 12.7.1 Company Overview
    • 12.7.2 Financial Overview
    • 12.7.3 Products/Services Offered
    • 12.7.4 Key Developments
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Strategies
  • 12.8 Geneferm Biotechnology Co. Ltd
    • 12.8.1 Company Overview
    • 12.8.2 Financial Overview
    • 12.8.3 Products/Services Offered
    • 12.8.4 Key Developments
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Strategies
  • 12.9 Frutarom
    • 12.9.1 Company Overview
    • 12.9.2 Financial Overview
    • 12.9.3 Products/Services Offered
    • 12.9.4 Key Developments
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Strategies
  • 12.1 Kyowa Hakko Bio Co. Ltd
    • 12.10.1 Company Overview
    • 12.10.2 Financial Overview
    • 12.10.3 Products/Services Offered
    • 12.10.4 Key Developments
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Strategies

13 Appendix

  • 13.1 Discussion Blueprint
Back to Top